Calculator
Amplite® Colorimetric Alanine Aminotransferase Assay Kit *Blue Color*
Alanine aminotransferase (ALT), also called serum glutamate pyruvic transaminase (GPT), is a member of transferase family. It catalyzes the reversible transfer of an alpha-amino group between alanine and glutamate, and is an important enzyme in amino acid metabolism. ALT is found mainly in liver and small amount in heart, muscle, and kidneys. In healthy subjects, serum ALT levels are low. However, when cells are damaged, such as acute and chronic hepatitis, obstructive jaundice, carcinoma of liver, myocardial infarction, ALT may leak into the blood stream and the ALT levels are significantly elevated. Therefore, determination of serum ALT level has great clinical and diagnostic significance. Amplite® Colorimetric Alanine Aminotransferase Assay Kit provides a quick and sensitive method for the measurement of ALT in various biological samples. ALT catalyzes the reaction of alanine and α-ketoglutarate to pyruvate and glutamate. The product glutamate is measured by the generation of a blue color product through an enzyme coupled reaction cycle. The signal can be read by an absorbance microplate reader at an absorbance ratio of A570 nm to A610 nm. With the Amplite® Colorimetric Alanine Aminotransferase Assay Kit as little as 10 mU/mL ALT was detected in a 100 µL reaction volume. The assay is robust, and can be readily adapted for a wide variety of applications.
Example protocol
AT A GLANCE
Protocol Summary
- Prepare ALT working solution (50 µL)
- Add ALT standards or test samples (50 µL)
- Incubate at 37 °C for 60 mins to 120 mins
- Monitor absorbance increase at the absorbance ratio of A570nm/A610nm
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles.
1. ALT standard solution (100 U/mL)
Add 100 µL DPBS into the vial of ALT Positive Control (Component D) to make 100 U/mL ALT standard solution.2. NAD solution (100X)
Add 100 µL of ddH2O into the vial of NAD (Component C) to have 100X NAD solution.PREPARATION OF STANDARD SOLUTION
For convenience, use the Serial Dilution Planner:
https://www.aatbio.com/tools/serial-dilution/13803
https://www.aatbio.com/tools/serial-dilution/13803
ALT standard
Add 10 µL of 100 U/mL ALT standard solution into 990 µL DPBS buffer with 0.1% BSA to generate 1 U/mL ALT standard solution (ALT7). Take 1 U/mL ALT standard solution and perform 1:2 serial dilutions in DPBS buffer with 0.1% BSA to get serial dilutions of ALT standard (ALT6 - ALT1).PREPARATION OF WORKING SOLUTION
- Add 10 mL of ALT Assay Buffer (Component B) into the bottle of ALT Enzyme Mixture (Component A) and mix well.
- Add the whole vial of 100X NAD solution into the ALT Enzyme Mixture solution to make ALT working solution.
Note This ALT working solution is enough for two 96-well plates. It is unstable at room temperature, and should be used promptly within 2 hours and avoid exposure to light. Alternatively, one can make a 50X of ALT Enzyme Mixture stock solution by adding 200 μL of H2O into the bottle of Component A, and then prepare the ALT working solution by mix the stock solution with assay buffer (Component B) and 100X NAD solution proportionally.
SAMPLE EXPERIMENTAL PROTOCOL
Table 1. Layout of ALT standards and test samples in a clear, white, or black with clear bottom 96-well microplate. ALT= ALT Standards (ALT1 - ALT7, 15.6 to 1000 mU/mL), BL=Blank Control, TS=Test Samples
Table 2. Reagent composition for each well.
| BL | BL | TS | TS |
| ALT1 | ALT1 | ... | ... |
| ALT2 | ALT2 | ... | ... |
| ALT3 | ALT3 | ||
| ALT4 | ALT4 | ||
| ALT5 | ALT5 | ||
| ALT6 | ALT6 | ||
| ALT7 | ALT7 |
| Well | Volume | Reagent |
| ALT1 - ALT7 | 50 µL | Serial Dilutions (15.6 to 1000 mU/mL) |
| BL | 50 µL | DPBS with 0.1% BSA |
| TS | 50 µL | test sample |
- Prepare ALT standards (ALT), blank controls (BL), and test samples (TS) according to the layout provided in Tables 1 and 2. For a 384-well plate, use 25 µL of reagent per well instead of 50 µL.
Note Dilute the test samples to the concentration range in DPBS buffer with 0.1% BSA if needed. - Add 50 µL of ALT working solution to each well of ALT standard, blank control, and test samples to make the total ALT assay volume of 100 µL/well. For a 384-well plate, add 25 µL of ALT working solution into each well instead, for a total volume of 50 µL/well.
- Incubate the reaction at 37°C for 60 min to 120 minutes, protected from light.
Note The background of Blank Control increases with time. - Monitor the absorbance increase with an absorbance plate reader at the absorbance ratio of A570nm/A610nm.
Citations
View all 9 citations: Citation Explorer
Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease
Authors: Liu, Pengfei and Anandhan, Annadurai and Chen, Jingjing and Shakya, Aryatara and Dodson, Matthew and Ooi, Aikseng and Chapman, Eli and White, Eileen and Garcia, Joe GN and Zhang, Donna D
Journal: Redox Biology (2022): 102570
Authors: Liu, Pengfei and Anandhan, Annadurai and Chen, Jingjing and Shakya, Aryatara and Dodson, Matthew and Ooi, Aikseng and Chapman, Eli and White, Eileen and Garcia, Joe GN and Zhang, Donna D
Journal: Redox Biology (2022): 102570
Reparative Efficacy of Liposome-Encapsulated Oleanolic Acid against Liver Inflammation Induced by Fine Ambient Particulate Matter and Alcohol in Mice
Authors: Wei, Ching-Ting and Wang, Yu-Wen and Wu, Yu-Chiuan and Lin, Li-Wei and Chen, Chia-Chi and Chen, Chun-Yin and Kuo, Shyh-Ming
Journal: Pharmaceutics (2022): 1108
Authors: Wei, Ching-Ting and Wang, Yu-Wen and Wu, Yu-Chiuan and Lin, Li-Wei and Chen, Chia-Chi and Chen, Chun-Yin and Kuo, Shyh-Ming
Journal: Pharmaceutics (2022): 1108
Pharmacologic IRE1/XBP1s activation promotes systemic adaptive remodeling in obesity
Authors: Madhavan, Aparajita and Kok, Bernard P and Rius, Bibiana and Grandjean, Julia and Alabi, Adekunle and Albert, Verena and Sukiasyan, Ara and Powers, Evan T and Galmozzi, Andrea and Saez, Enrique and others,
Journal: Nature communications (2022): 1--9
Authors: Madhavan, Aparajita and Kok, Bernard P and Rius, Bibiana and Grandjean, Julia and Alabi, Adekunle and Albert, Verena and Sukiasyan, Ara and Powers, Evan T and Galmozzi, Andrea and Saez, Enrique and others,
Journal: Nature communications (2022): 1--9
Reparative and toxicity-reducing effects of liposome-encapsulated saikosaponin in mice with liver fibrosis
Authors: Shiu, Li-Yen and Huang, Han Hsiang and Chen, Chun Yin and Cheng, Hsia-Ying and Chen, Chih I and Kuo, Shyh Ming
Journal: Bioscience Reports (2020)
Authors: Shiu, Li-Yen and Huang, Han Hsiang and Chen, Chun Yin and Cheng, Hsia-Ying and Chen, Chih I and Kuo, Shyh Ming
Journal: Bioscience Reports (2020)
References
View all 226 references: Citation Explorer
Pegylated interferon alpha-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase
Authors: Kainuma M, Furusyo N, Azuma K, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Shimoda S, Hayashi J.
Journal: Hepatol Res (2012): 33
Authors: Kainuma M, Furusyo N, Azuma K, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Shimoda S, Hayashi J.
Journal: Hepatol Res (2012): 33
Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males
Authors: Wang R, Lu Q, Feng J, Yin F, Qin C, Liu B, Liu Y, Liu X.
Journal: Endocrine (2012): 70
Authors: Wang R, Lu Q, Feng J, Yin F, Qin C, Liu B, Liu Y, Liu X.
Journal: Endocrine (2012): 70
Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients with Chronic HCV Infection
Authors: Tapper EB, Cohen EB, Patel K, Bacon B, Gordon S, Lawitz E, Nelson D, Nasser IA, Challies T, Afdhal N.
Journal: Clin Gastroenterol Hepatol. (2012)
Authors: Tapper EB, Cohen EB, Patel K, Bacon B, Gordon S, Lawitz E, Nelson D, Nasser IA, Challies T, Afdhal N.
Journal: Clin Gastroenterol Hepatol. (2012)
Association of serum alanine aminotransferase and gamma-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease
Authors: Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, Shim SY, Shin SR, Han AL, Yoon SJ, Kim HC.
Journal: Korean J Hepatol (2011): 27
Authors: Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, Shim SY, Shin SR, Han AL, Yoon SJ, Kim HC.
Journal: Korean J Hepatol (2011): 27
Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C
Authors: Sanai FM, Helmy A, Dale C, Al-Ashgar H, Abdo AA, Katada K, AlMana H, Saadeh M, Al-Hussaini H, AlQuaiz M, Hashem A, AlSwat K, Bzeizi KI, Marotta PJ.
Journal: Liver Int (2011): 1039
Authors: Sanai FM, Helmy A, Dale C, Al-Ashgar H, Abdo AA, Katada K, AlMana H, Saadeh M, Al-Hussaini H, AlQuaiz M, Hashem A, AlSwat K, Bzeizi KI, Marotta PJ.
Journal: Liver Int (2011): 1039
Page updated on March 11, 2025
Safety data sheet